90
Views
2
CrossRef citations to date
0
Altmetric
Review

Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery

Pages 365-370 | Published online: 24 Dec 2022

References

  • AgnelliGBergqvistDCohenATRandomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgeryBr J Surg20059212122016175516
  • AndersenJCAdvances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgerySemin Thromb Hemost2004306091815630666
  • BauerKAErikssonBILassenMRFondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgeryN Engl J Med200134513051011794149
  • BauerKAHawkinsDWPetersPCFondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitorsCardiovasc Drug Rev200220375212070533
  • BijsterveldNRMoonsAHBoekholdtSMAbility of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteersCirculation20021062550412427650
  • ChengJWFondaparinux: a new antithrombotic agentClin Ther200224175769 discussion 171912501872
  • ChoayJPetitouMLormeauJStructure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high antifactor Xa activityBiochem Biophys Res Commun198311649296651824
  • CohenATDavidsonBLGallusASEfficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ20063327537325916439370
  • [CPMP] Committee for Proprietary Medicinal ProductsPoint to consider on clinical investigation of medicnal products for prophylaxis of iintra-and postoperative venous thromboembolic risk: The European Agency for the Evaluation of Medical Products, London, UK2000 200, CPMP/EWP/707/98
  • DavidssonBTurpieAKwongLFLEXTRA: Early Vs delayed initiation of postoperative fondaparinux prophylaxis after joint replacement: A clinical outcome study [abstract]2005 Congress ISTH 2005
  • ErikssonBIBauerKALassenMRFondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgeryN Engl J Med2001345129830411794148
  • ErikssonBILassenMRDuration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind studyArch Intern Med200316313374212796070
  • GeertsWHeitJClagettGPrevention of venous thromboembolismChest2002121207812065386
  • GeertsWHPineoGFHeitJAPrevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyChest2004126Suppl 3S 338400
  • HoppensteadtDWalengaJMFareedJHeparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiationHematol Oncol Clin North Am2003173134112627673
  • HuversFSlappendelRBenraadBTreatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acidNeth J Med200563184615952489
  • KeamSJGoaKLFondaparinux sodiumDrugs200262167385 discussion 1686-712109927
  • LassenMRBauerKAErikssonBIPostoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparisonLancet2002359931917152012049858
  • LassenMRBauerKAErikssonBAbscence of transaminase increase after 4-week administrationof fondaparinux (Arixtra), a new synthetic and selective inhibition of factor Xa, in the PENTHIFRA-plus studyJ Thormb Haemost2003ISupplP2052
  • LindahlUBackstromGHookMStructure of the antithrombin-binding site in heparinProc Natl Acad Sci U S A1979763198202226960
  • LoboBLPharmacoeconomic considerationsAm J Health Syst Pharm200360Suppl 7S11414650861
  • LoweGSandercockPRosendaalFPrevention of venous thromboembolism after major orthopaedic surgery: Is fondaparinux an advance?Lancet2003362504512932379
  • NijkeuterMHuismanMVPentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic reviewCurr Opin Pulm Med2004103384415316429
  • ReynoldsNAPerryCMScottLJFondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgeryDrugs20046415759615233593
  • TurpieABauerKCapriniJFondaparinux combined withintermittent pneumatic compression (IPC) versus IPC alone in the prevention of VTE after major abdominal surgery2005 Results of the APOLLO study [abstract]. XX Congress ISTH 2005
  • TurpieAGBauerKAErikssonBIFondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studiesArch Intern Med200216218334012196081
  • TurpieAGBauerKAErikssonBIPostoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialLancet200235993191721612049860
  • TurpieAGBauerKAErikssonBISuperiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsChest2004126501815302737
  • TurpieAGGallusASHoekJAA synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacementN Engl J Med20013446192511228275
  • VormfeldeSEnoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgeryLancet2002360170112457831